| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Galera Therapeutics, Inc.
13D/A
Amendment 1
GRTX · 36338D108
|
30.2% |
5/29/2026
Event 5/15/2026
|
|||
| Emerald Bioventures, LLC | 30.2% | ||||
| Timothy Opler | 30.2% | ||||
|
Galera Therapeutics, Inc.
13D
GRTX · 36338D108
|
26.5% |
4/27/2026
Event 4/7/2026
|
|||
| Emerald Bioventures, LLC | 26.5% | ||||
| Timothy Opler | 26.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.